Table 1 Demographic and clinical data of subjects (m ± sd). Gender, 28-day Finale (S: survivor, D: death), age, ALT, TBIL, creatinine(Crea), cardiac troponin (cTnI), Total white blood cell (WBC) count, neutrophil count, monocytes(MONO), lymphocyte(LY), thrombin time(TT), international normalized ratio, (INR) and procalcitonin(PCT)

Gender(F/M)

28- Day Finale(S/D)

(13/7)

(15/5)

(7/5)

(2/10)

-

-

Age(years)

55.00 ± 12.18

46.41 ± 14.27

0.51

ALT (U/L)

117.81 ± 210.39

57.27 ± 63.25

0.249

TBIL (umol/L)

21.07 ± 17.63

14.05 ± 4.89

0.037

Crea (umol/L)

167.75 ± 169.10

85.88 ± 60.95

0.078

CTnl (µg/L)

0.33 ± 0.20

0.80 ± 0.14

0.121

WBC (10^9/L)

13.72 ± 9.61

11.45 ± 5.27

0.50

NEUT (10^9/L)

11.76 ± 9.84

8.60 ± 4.82

0.62

MONO (10^9/L)

1.20 ± 2.17

0.63 ± 0.37

0.063

LY (10^9/L)

3.80 ± 6.30

0.94 ± 0.43

0.002

TT (min)

15.57 ± 1.72

15.50 ± 1.97

0.045

INR (s)

1.23 ± 0.17

1.20 ± 0.13

0.164

PCT (ng /ml)

40.39 ± 39.63

11.69 ± 25.64

0.007